One Site. Any Patient. Total Access
Science 37 is the first and only FDA-inspected direct-to-patient clinical trial site. Decentralized clinical trial (DCT) operating model branded MetaSite allows sponsors to deliver research directly to patients' homes. Full suite including recruitment, home visits, remote monitoring, telehealth. Acquired by eMed in 2024 for ~$38M.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountAug 2020
Mar 2018
Apr 2017
Jan 2016
Oct 2015
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Health insurance company using technology to make health care simple, affordable, and accessible.
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Fitness wearable company offering a subscription-based health tracker that measures strain, recov...
Digital healthcare platform connecting patients, hospitals, and doctors in China for online consu...
Digital health insurance company and healthcare super-app offering personalized health insurance,...
